
Constant improvement of genome-decryption tools makes it possible for us to enhance our understanding of the various genetic mechanisms and discover molecular biomarkers associated with diseases.
IntegraGen’s vocation is to establish the link between these innovations and medical practise by developing tools specifically intended for clinical use.
IntegraGen’s researchers and our academic partners have succeeded in developing biomarkers for use as diagnostic tools in the fields of autism, oncology, diabetes and obesity. These will allow clinical practitioners to improve patient care by contributing, in particular, to earlier diagnosis of family forms of autism or improving the medico-surgical strategy relative to treatment of certain cancers.
Thanks to its scientific knowledge and its technological and bioinformatics know-how, IntegraGen has become one of the reference partners for teams working in molecular genetics research. At the heart of a network of geneticists, clinical practitioners and biostatisticians and with perfect command of the most advanced technologies in genomics (DNA and RNA sequencing and genotyping), bioinformatics and biostatistics, IntegraGen is a major actor in clinical genomics at the service of patients, clinical practitioners and researchers.